Gram Research analysis of a 2026 mouse study found that the probiotic Lactiplantibacillus plantarum PS128 may reduce Parkinson’s-like changes by acting on the gut. In these mice, it improved movement, reduced harmful protein buildup in the gut and brain, and raised vitamin D and calcium levels. These results are promising but have not yet been tested in people.
Gram Research analysis of a 2026 study in Biomedicine & Pharmacotherapy found that a probiotic called Lactiplantibacillus plantarum PS128 may slow Parkinson’s-like changes that start in the gut. Parkinson’s disease involves a harmful protein, alpha-synuclein, that clumps together and may begin in the gut before traveling to the brain through the vagus nerve, a long nerve linking the gut and brain. Researchers gave the probiotic to mice with a Parkinson’s-like condition. The mice moved better, had fewer digestive problems, and showed fewer harmful protein clumps in their guts and brains. The probiotic also raised blood calcium and vitamin D levels and shifted the mix of bacteria in the gut. These results come mainly from mice and a zebrafish experiment, so they do not yet show that the same effects happen in people.
Key Statistics
A 2026 mouse study published in Biomedicine & Pharmacotherapy found that the probiotic PS128 reduced harmful alpha-synuclein protein buildup in both the gut and brain of mice with a Parkinson’s-like condition.
A 2026 study in Biomedicine & Pharmacotherapy reported that PS128 raised blood calcium and 25-hydroxyvitamin D levels in mice, with gene analysis pointing to calcium signaling and vitamin D metabolism as the main pathways affected.
The Quick Take
- What they studied: Whether a specific probiotic could slow Parkinson’s-like changes by working through the gut, and how it might do so.
- Who participated: Mice that were given a chemical known to produce Parkinson’s-like symptoms. Zebrafish were also used in a separate test. The number of animals was not stated in the information provided, and no people took part.
- Key finding: The probiotic improved movement and digestion and reduced harmful protein clumps in the gut and brain. It also raised blood calcium and vitamin D levels. The exact size of these changes was not included in the summary provided, so the strength of the effect is not clear.
- What it means for you: This is early animal research. It does not show that a probiotic can treat or prevent Parkinson’s disease in people. If you have concerns about Parkinson’s or gut health, talk with a doctor before starting any supplement.
The Research Details
The researchers used a mouse model of Parkinson’s disease. They gave mice a chemical called rotenone, which damages brain cells in a way that resembles Parkinson’s. Some of these mice then received the probiotic PS128, while others did not, so the two groups could be compared.
To study how the probiotic worked, the team looked at the mice’s movement, digestion, and the harmful protein clumps in their intestines and brains. They also checked the activity of special gut cells that release hormones. The researchers measured blood levels of calcium and vitamin D, and they studied the genes active in the colon to find which biological pathways changed.
The team also tested whether PS128 directly activates gut cells. They used zebrafish, which are small, see-through fish, and filmed calcium signals in real time. They then examined which bacteria were present in the mice’s guts, using a method that identifies bacteria by their genetic code.
Using animal models lets scientists control conditions closely and study the gut and brain together, which is difficult in people. Watching the same changes across movement, gut tissue, brain tissue, blood tests, and gut bacteria helps build a more complete picture. Zebrafish imaging showed the probiotic’s effect on gut cells in a live setting, which supports the idea that it acts directly rather than only by chance.
The study uses several different types of tests that point in the same direction, which makes the findings more believable. However, the summary does not report the number of animals per group, the exact measurements, or whether the results were checked by an independent team. Because the work was done in mice and fish, the results may not translate to people. Readers should view this as promising early evidence rather than proof.
What the Results Show
The main result was that PS128 appeared to help the Parkinson’s-like mice in several ways. Their movement improved, and their digestive problems eased. The researchers also found that the probiotic reversed an abnormal increase in certain gut cells, which normally release hormones that help control digestion.
Another key finding involved the harmful protein alpha-synuclein. In the Parkinson’s-like mice, this protein built up in the gut, in the nerve network that controls the gut, and in a brain area called the substantia nigra, which is damaged in Parkinson’s disease. The probiotic reduced these buildups in both the gut and the brain.
The researchers also found that PS128 activated gut cells directly, based on the zebrafish experiment. This suggests the probiotic may send signals from the gut that reach the brain, although this link still needs more study.
Finally, the probiotic raised blood calcium and vitamin D levels. The gene analysis pointed to calcium signaling and vitamin D metabolism as the main pathways affected, and the blood tests matched these changes. The researchers also found that the probiotic shifted the mix of gut bacteria, and some bacteria changed in step with the protein buildup and calcium levels.
The study suggests that changes in gut bacteria may be linked to both the amount of harmful protein and calcium regulation. Because the researchers saw these connections in their analysis, they propose that the probiotic works through a chain of effects that begins in the gut. Vitamin D and calcium are important for nerve and muscle health, so their increase could be part of how the probiotic supports overall function. These links are interesting, but the study does not prove that any one of them causes the others.
The researchers note that PS128 has already shown brain-protective benefits in other Parkinson’s models and in some patients. This new work adds an explanation for how the probiotic might do this, focusing on the gut-brain connection. It supports the growing idea that Parkinson’s may start in the gut for some people, which has been discussed in earlier research on the gut-brain axis.
The most important limitation is that the study was done in mice and zebrafish, not in people. Animal brains and guts differ from human ones, so results may not carry over. The Parkinson’s-like condition was created with a chemical, which is not the same as the natural disease in people. The summary also does not state how many animals were used, so it is hard to judge how strong the evidence is. Additionally, the study shows links between gut bacteria, protein buildup, and calcium, but it does not prove cause and effect. More research in people would be needed before any conclusions about treatment could be drawn.
The Bottom Line
Based on this study alone, there is not enough evidence to recommend PS128 as a treatment for Parkinson’s disease. The findings are promising and suggest the gut may be a useful target for future research. Confidence in the animal results is moderate, while confidence that the same effects happen in people is currently low. Anyone interested in probiotics should follow medical advice rather than relying on this study.
Researchers studying Parkinson’s disease and the gut-brain connection will find this study especially useful. People with Parkinson’s, or those with a family history, may find it interesting, but they should discuss any supplement with their neurologist before trying it. Healthy adults who are curious about gut health should know that this study does not show a benefit for them. People taking medications, pregnant people, and children should check with a doctor before using any probiotic.
Because this is early research in animals, it may take many years of clinical trials in people before any probiotic could be considered for Parkinson’s care. Even if future human studies are positive, results would probably take months to appear and would need to be confirmed over longer periods. Anyone seeking to support gut health today should focus on established habits such as a varied diet, regular activity, and medical care.
Frequently Asked Questions
Can a probiotic help with Parkinson’s disease?
Early animal research suggests that the probiotic PS128 may ease Parkinson’s-like changes by acting on the gut. Mice given the probiotic moved better and had less harmful protein buildup. These findings have not been tested in people, so they cannot yet guide treatment.
What is alpha-synuclein and why does it matter in Parkinson’s?
Alpha-synuclein is a protein that can clump together in brain and nerve cells. These clumps are linked to the damage seen in Parkinson’s disease. Some research suggests the clumps may start in the gut and travel to the brain through the vagus nerve.
How does gut bacteria affect the brain?
Gut bacteria may influence the brain through nerves such as the vagus nerve and through chemical signals that the gut sends out. Researchers call this the gut-brain axis. Studies in mice suggest that changing gut bacteria may affect protein buildup and nerve health.
Should I take a probiotic if I have Parkinson’s?
This study was done only in mice and zebrafish, so it does not show that probiotics help people with Parkinson’s. Anyone with Parkinson’s should talk with their neurologist before taking a probiotic or any other supplement.
Want to Apply This Research?
- Track daily bowel movements, using a simple scale such as the Bristol Stool Chart, and log the number of days per week with regular, comfortable bowel movements. Also record any probiotic use and the product name, so changes can be linked to specific routines.
- Encourage users to eat a varied diet with fiber from vegetables, fruits, beans, and whole grains, which feed beneficial gut bacteria. Remind users to speak with a doctor before starting any probiotic, especially if they have a neurological condition or take other medications.
- Over the long term, users can log weekly notes on digestion, energy, and movement, and share these summaries with their healthcare provider. If a clinician has ordered blood tests for calcium or vitamin D, the app can store results so trends are easy to review at each visit.
This article summarizes early research done in mice and zebrafish, not in people. The findings do not prove that any probiotic can prevent, treat, or slow Parkinson’s disease in humans. This information is for education only and is not medical advice. Anyone with Parkinson’s disease, digestive symptoms, or concerns about calcium or vitamin D should consult a qualified healthcare provider before making changes to their diet, supplements, or treatment.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.